iRadimed Corp IRMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IRMD is a good fit for your portfolio.
News
-
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
-
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
-
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
-
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
Trading Information
- Previous Close Price
- $42.44
- Day Range
- $41.17–42.15
- 52-Week Range
- $36.12–51.04
- Bid/Ask
- $16.59 / $65.93
- Market Cap
- $525.18 Mil
- Volume/Avg
- 43,641 / 59,702
Key Statistics
- Price/Earnings (Normalized)
- 28.38
- Price/Sales
- 8.24
- Dividend Yield (Trailing)
- 0.36%
- Dividend Yield (Forward)
- 0.36%
- Total Yield
- 0.37%
Company Profile
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 148
- Website
- https://www.iradimed.com
Comparables
Valuation
|
Metric
|
IRMD
|
MMSI
|
RXST
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.38 | 24.38 | — |
Price/Book Value | 7.52 | 3.53 | 11.82 |
Price/Sales | 8.24 | 3.41 | 20.28 |
Price/Cash Flow | 27.87 | 19.90 | — |
Price/Earnings
IRMD
MMSI
RXST
Financial Strength
|
Metric
|
IRMD
|
MMSI
|
RXST
|
|---|---|---|---|
Quick Ratio | 3.80 | 3.81 | 7.05 |
Current Ratio | 4.65 | 5.45 | 8.06 |
Interest Coverage | — | 8.07 | −15.68 |
Quick Ratio
IRMD
MMSI
RXST
Profitability
|
Metric
|
IRMD
|
MMSI
|
RXST
|
|---|---|---|---|
Return on Assets (Normalized) | 22.37% | 9.43% | −17.04% |
Return on Equity (Normalized) | 26.75% | 14.77% | −21.78% |
Return on Invested Capital (Normalized) | 23.92% | 11.47% | −20.20% |
Return on Assets
IRMD
MMSI
RXST
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Vnyrjddv | Rlzqmrw | $185.4 Bil | |
SYK
| Stryker Corp | Pfmvvcyfj | Rvbp | $128.2 Bil | |
BSX
| Boston Scientific Corp | Mrctzxj | Gyzwtf | $107.7 Bil | |
MDT
| Medtronic PLC | Nzngmgk | Blvznb | $105.2 Bil | |
DXCM
| DexCom Inc | Ssblbsmcn | Qsfx | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Xcwyvjgnlw | Gmbwh | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Xdwkcnjs | Jqpp | $24.6 Bil | |
ALGN
| Align Technology Inc | Gqdzyjx | Kyjyp | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Tkwvwcz | Zjtjvsl | $18.7 Bil | |
PODD
| Insulet Corp | Mdcjlxxpwf | Zknjr | $11.5 Bil |